Eltze E - Search Results

1

[New markers for pharmacological targeting in bladder cancer with lymph node metastasis].

Herrmann E, Eltze E, Köpke T, Bolenz C, Bierer S, Neumann J, Hertle L, Wülfing C. Herrmann E, et al. Among authors: eltze e. Aktuelle Urol. 2007 Sep;38(5):392-7. doi: 10.1055/s-2007-980110. Aktuelle Urol. 2007. PMID: 17907066 German.

2

The role of the endothelin axis and microvessel density in bladder cancer - correlation with tumor angiogenesis and clinical prognosis.

Herrmann E, Bögemann M, Bierer S, Eltze E, Toma MI, Köpke T, Hertle L, Wülfing C. Herrmann E, et al. Among authors: eltze e. Oncol Rep. 2007 Jul;18(1):133-8. Oncol Rep. 2007. PMID: 17549358

3

VEGF-C, VEGF-D and Flt-4 in transitional bladder cancer: relationships to clinicopathological parameters and long-term survival.

Herrmann E, Eltze E, Bierer S, Köpke T, Görge T, Neumann J, Hertle L, Wülfing C. Herrmann E, et al. Among authors: eltze e. Anticancer Res. 2007 Sep-Oct;27(5A):3127-33. Anticancer Res. 2007. PMID: 17970053 Free article.

4

[Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].

Wülfing C, Eltze E, Von Struensee D, Wülfing P, Bode ME, Bettendorf O, Piechota H, Hertle L. Wülfing C, et al. Among authors: eltze e. Aktuelle Urol. 2004 Aug;35(4):331-8. doi: 10.1055/s-2004-818537. Aktuelle Urol. 2004. PMID: 15459875 German.

5

[Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].

Wülfing C, von Struensee D, Bierer S, Bögemann M, Hertle L, Eltze E. Wülfing C, et al. Among authors: eltze e. Aktuelle Urol. 2005 Sep;36(5):423-9. doi: 10.1055/s-2004-830253. Aktuelle Urol. 2005. PMID: 16163605 German.

6

[Lymphangiogenesis axis in bladder carcinoma. An analysis with tissue microarray technology].

Herrmann E, Eltze E, Bierer S, Hertle L, Wülfing C. Herrmann E, et al. Among authors: eltze e. Urologe A. 2007 Sep;46(9):1254-6. doi: 10.1007/s00120-007-1492-5. Urologe A. 2007. PMID: 17676294 German. No abstract available.

7

Lymphangiogenesis in kidney cancer: expression of VEGF-C, VEGF-D and VEGFR-3 in clear cell and papillary renal cell carcinoma.

Bierer S, Herrmann E, Köpke T, Neumann J, Eltze E, Hertle L, Wülfing C. Bierer S, et al. Among authors: eltze e. Oncol Rep. 2008 Oct;20(4):721-5. Oncol Rep. 2008. PMID: 18813809

8

Expression of the endothelin axis in bladder cancer: relationship to clinicopathologic parameters and long-term survival.

Wülfing C, Eltze E, Yamini J, Wülfing P, Bierer S, Böcker W, Hertle L, Semjonow A, Sievert KD. Wülfing C, et al. Among authors: eltze e. Eur Urol. 2005 May;47(5):593-600. doi: 10.1016/j.eururo.2004.12.019. Epub 2005 Jan 26. Eur Urol. 2005. PMID: 15826749

9

Cox-2 and Her2/neu co-expression in invasive bladder cancer.

Eltze E, Wülfing C, Von Struensee D, Piechota H, Buerger H, Hertle L. Eltze E, et al. Int J Oncol. 2005 Jun;26(6):1525-31. Int J Oncol. 2005. PMID: 15870865

10

The endothelin axis in urologic tumors: mechanisms of tumor biology and therapeutic implications.

Herrmann E, Bögemann M, Bierer S, Eltze E, Hertle L, Wülfing C. Herrmann E, et al. Among authors: eltze e. Expert Rev Anticancer Ther. 2006 Jan;6(1):73-81. doi: 10.1586/14737140.6.1.73. Expert Rev Anticancer Ther. 2006. PMID: 16375646 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters